| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 07/29/2010 | US20100190712 Use of peptide yy, alone or in combination with glucagon-like peptide, for use in medicine |
| 07/29/2010 | US20100190711 Big gastrin i as a therapeutic agent |
| 07/29/2010 | US20100190705 Suppression of glial fibrillary acidic protein |
| 07/29/2010 | US20100190698 Neuroprotective peptide inhibitors of AP-1 signaling and uses therefor |
| 07/29/2010 | US20100189830 Sweet Gum Fruit Extract as a Therapeutic Agent |
| 07/29/2010 | US20100189819 Neuro-degenerative inhibitor, neuro-endocrine modulator, and neuro-cerebral metabolism enhancer |
| 07/29/2010 | US20100189818 Sorbic and benzoic acid and derivatives thereof enhance the activity of a neuropharmaceutical |
| 07/29/2010 | US20100189803 Ejaculum of animals as medicinal material and uses thereof in medicaments for treatment of diseases such as tumors, depression, etc. |
| 07/29/2010 | US20100189793 Electrophoretic transdermal delivery system |
| 07/29/2010 | US20100189790 Delayed release rasagiline formulation |
| 07/29/2010 | US20100189778 Opioid delivery system |
| 07/29/2010 | US20100189770 Bioerodible patch |
| 07/29/2010 | US20100189713 Use of Semaphorin 6A for Promoting Myelination and Oligodendrocyte Differentiation |
| 07/29/2010 | US20100189698 Treatment or prophylaxis of a neurological or neuropsychiatric disorders via ocular administration |
| 07/29/2010 | US20100189696 Lithium stimulation of cord blood stem cell proliferation and growth factor production |
| 07/29/2010 | US20100189690 Pseudotyping of retroviral vectors, methods for production and use thereof for targeted gene transfer and high throughput screening |
| 07/29/2010 | US20100189686 Albumin Fusion Proteins |
| 07/29/2010 | US20100189684 USE OF gp130 ACTIVATORS IN DIABETIC NEUROPATHY |
| 07/29/2010 | US20100189655 Methods for treating headache |
| 07/29/2010 | US20100189646 Carbazole Derivatives as Functional 5-HT6 Ligands |
| 07/29/2010 | CA2750510A1 Treatment of neurotrophic factor mediated disorders |
| 07/29/2010 | CA2750450A1 Novel indolyl-oxadiazolyl-diazabicyclononane derivatives and their medical and diagnostical use |
| 07/29/2010 | CA2750449A1 New adenosine receptor ligands and uses thereof |
| 07/29/2010 | CA2750447A1 N-oxides of diazabicyclononyl pyrimidine derivatives and their medical use |
| 07/29/2010 | CA2750339A1 Bumetanide, furosemide, piretanide, azosemide, and torsemide analogs, compositions and methods of use |
| 07/29/2010 | CA2750265A1 Methods of alleviating or treating signs and/or symptoms associated with moderate to severe parkinson's disease |
| 07/29/2010 | CA2750106A1 Poly (adp-ribose) polymerase (parp) inhibitors |
| 07/29/2010 | CA2750028A1 Sorbic and benzoic acid and derivatives thereof enhance the activity of a neuropharmaceutical |
| 07/29/2010 | CA2749955A1 Solid pharmaceutical composition comprising amlodipine and losartan with improved stability |
| 07/29/2010 | CA2749123A1 Preparation and therapeutic applications of (2s,3r)-n-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide |
| 07/29/2010 | CA2748864A1 Amino-heterocyclic compounds used as pde9 inhibitors |
| 07/29/2010 | CA2747801A1 N-substituted saturated heterocyclic sulfone compounds with cb2 receptor agonistic activity |
| 07/28/2010 | EP2210901A1 Antibody capable of specifically binding to a oligomer, and use thereof |
| 07/28/2010 | EP2210892A2 Neurologically-active compounds |
| 07/28/2010 | EP2210891A1 New adenosine receptor ligands and uses thereof |
| 07/28/2010 | EP2210878A1 Therapeutic agent for trpv1-mediated disease |
| 07/28/2010 | EP2210872A1 New crystalline form III of agometalin, the process for its preparation and pharmaceutical compositions containing it |
| 07/28/2010 | EP2210617A1 Mammalian cells secreting Neurturin and their therapeutic use |
| 07/28/2010 | EP2210611A1 Use of the sequence encoding the carboxyl-terminal domain of the heavy chain of tetanus toxin as a drug |
| 07/28/2010 | EP2210603A1 Pharmaceutical composition for inhibiting the accumulation of amyloid- b protein |
| 07/28/2010 | EP2210598A2 Anticonvulsant amino acids for the treatment of pain |
| 07/28/2010 | EP2209804A1 Monoclonal antibody for app |
| 07/28/2010 | EP2209797A2 Modification of intrinsically disordered sequences for preparing vaccines |
| 07/28/2010 | EP2209791A1 Heterocyclic derivatives |
| 07/28/2010 | EP2209782A1 Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidine derivatives and their medical use |
| 07/28/2010 | EP2209768A1 5,6-diaryl pyridines substituted in the 2- and 3-position, preparation thereof and therapeutic use thereof |
| 07/28/2010 | EP2209488A1 Fgf9-related methods for treating anxiety |
| 07/28/2010 | EP2209373A1 N-substituted oxindoline derivatives as calcium channel blockers |
| 07/28/2010 | EP1963271B1 Quinolone m1 receptor positive allosteric modulators |
| 07/28/2010 | EP1421199B1 Compositions for treating neurodegenerative diseases |
| 07/28/2010 | CN1977903B Chinese medicine composition for treating dementia, and its preparation and use |
| 07/28/2010 | CN1905875B The use of quaternary pyridinium salts as vasoprotective agents |
| 07/28/2010 | CN1872081B Application of kudzuvine root flavone in preparing medicine for treating chronic insufficiency of blood supply for brain |
| 07/28/2010 | CN1548434B Benzothiophene compounds and their preparation and medicine use |
| 07/28/2010 | CN101790522A Substituted piperazinyl pyrazines and pyridines as 5-ht7 receptor antagonists |
| 07/28/2010 | CN101790518A Derivatives of 1-oxo-1,2-dihydroisoquinoline-5-carboxamides and of 4-oxo-3,4-dihydroquinazoline-8-carboxamides, preparation thereof and application thereof in therapeutics |
| 07/28/2010 | CN101790516A Novel substituted piperidones as hsp inducers |
| 07/28/2010 | CN101790515A trans-3-aza-bicyclo[3.1.0]hexane derivatives |
| 07/28/2010 | CN101790514A 1-oxo-isoindoline-4-carboxamide and 1-oxo-1,2,3,4-tetrahydroisoquinoline-5-carboxamide derivatives, preparation and therapeutic use thereof |
| 07/28/2010 | CN101790385A Molecules for targeting compounds to various selected organs, tissues or tumor cells |
| 07/28/2010 | CN101790377A Prophylactic or alleviating agent for peripheral nerve disorder induced by anti-cancer agent |
| 07/28/2010 | CN101790374A Use of kncq potassium channel openers for reducing symptoms of or treating disorders or conditions wherein the dopaminergic system is disrupted |
| 07/28/2010 | CN101787379A Preparation of microbial oil containing polyunsaturated fatty acids |
| 07/28/2010 | CN101787007A Dimeric sesquiterpene compound and applications thereof |
| 07/28/2010 | CN101786993A 1, 2, 3-triazole compound and application thereof in preparing indoleamine 2, 3-dioxygenase inhibitor |
| 07/28/2010 | CN101785859A Antidepressant medicament combination preparation, application method and application |
| 07/28/2010 | CN101785846A Traditional Chinese medicine combination and preparation method for intestinal depression disease treatment |
| 07/28/2010 | CN101785832A Traditional Chinese medicine preparation and preparation method thereof for skin disease treatment |
| 07/28/2010 | CN101785823A Traditional Chinese medicine combination and preparation method for malaise, palpitation and insomnia treatment |
| 07/28/2010 | CN101785816A Grass-leaved sweetflag extract, medicine composition with grass-leaved sweetflag extract, preparation method and application thereof |
| 07/28/2010 | CN101785803A Composition for suppressing cyclooxygenase and/or 5-lipoxygenase |
| 07/28/2010 | CN101785789A Method for preparing animal gall powder |
| 07/28/2010 | CN101785780A Preparation of cyanocobalamine and adenosine composition and preparation method thereof |
| 07/28/2010 | CN101785773A Use of metal supermolecular compound in preparation of medicament for treating alzheimer's disease |
| 07/28/2010 | CN101785762A Huperzine A orally disintegrating tablets and preparation method thereof |
| 07/28/2010 | CN101785753A Gastrodia elata genin transdermal gel for central nervous system disease treatment |
| 07/28/2010 | CN101785581A Smoking-cessation and health-care cigarette holders and using method thereof |
| 07/28/2010 | CN101385600B Chinese herbal medicine health-care silk quilt |
| 07/28/2010 | CN101347413B Quetiapine sustained release tablets and method of preparing the same |
| 07/28/2010 | CN101279020B Chinese medicinal composition for curing hyperkinetic symptom |
| 07/28/2010 | CN101091788B Oral liquid for stopping drug addiction |
| 07/28/2010 | CN101081091B Vision-improving and intelligent-improving beverage |
| 07/27/2010 | US7763747 Bis- and tris-dihydroxyaryl compounds and their methylenedioxy analogs; Alzheimer's disease; diabetes; A beta amyloidosis |
| 07/27/2010 | US7763738 ceramide-like inhibitors; novel intermediates formed during the synthesis; Glycosphingolipids |
| 07/27/2010 | US7763729 Bicyclic heteroaromatic derivatives |
| 07/27/2010 | US7763652 such as 9-Deoxy-9 beta -chloro-16,17,18,19,20-pentanor-15-cyclohexyl-2,2,3,3,13,14-hexadehydro-6-thia-prostaglandin F1, useful as drugs for sleep induction |
| 07/27/2010 | US7763646 beta-secretase inhibitors such as N-(3,5-difluorobenzyl)-N-{(2R)-2-hydroxy-3-[(3-iodobenzyl)amino]propyl}-5-methyl-N',N'-dipropylisophthalamide, used for reducing amyloid beta peptide formation |
| 07/27/2010 | US7763639 1-ethyl-4-[2-fluoro-3-(methylsulfonyl)phenyl]piperidine, havinf therapeutic effects against disorders in the central nervous system, such as dyskinesia |
| 07/27/2010 | US7763632 administering drugs succh as N-[2-diethylamino-5-{N-ethyl-N-(trifluoroacetyl)amino}pyrimidin-4-yl]-L-4'-{(pyrrolidin-1-yl) carbonyloxy}phenylalanine, for the treament asthma, multiple sclerosis, inflammatory bowel disease, ulcerative colitis, Crohn's disease, graft versus host disease and arthritis |
| 07/27/2010 | US7763626 composition for inhibition of opioid tolerance and opioid withdrawal-induced hyperalgesia comprising propentofylline, an opioid drug, and a pharmaceutically acceptable carrier, wherein said composition is administered intrathecally at a dose of propentofylline of 10 micrograms |
| 07/27/2010 | US7763623 Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia |
| 07/27/2010 | US7763617 Pyrazolopyridine-4-yl pyridazinone derivatives and addition salts thereof, and PDE inhibitors comprising the same derivatives or salts as active ingredient |
| 07/27/2010 | US7763603 Manipulation of brain CDP-diacylglycerol and uses thereof |
| 07/27/2010 | US7763597 Salts |
| 07/27/2010 | US7763591 Hepatocyte growth factor gene as an active therapeutic agent; biodrugs; Parkinson's disease, Alzheimer's disease, spinal cord injury, diabetic peripheral neuritis, and ischemic cerebrovascular disorders (cerebral infarction, cerebral haemorrhage) |
| 07/27/2010 | US7763588 Administering flavonoids and oxidation resistance compound; Alzheimer's disease; Parkinson's disease; Huntington's disease |
| 07/27/2010 | US7763435 Method for diagnosis of alzheimer's disease with determination of LASP-1 immunoreactivity |
| 07/27/2010 | US7763284 Method for treating or preventing symptoms associated with menopause |
| 07/27/2010 | US7763278 As cholesterol lowering agents and for treatment of cardiovascular disorders |
| 07/27/2010 | US7763249 Brain protein specific immunoglobulin for use in diagnosis, prevention and treatment of alzheimer's disease |